Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Galipeau

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Cytotherapy|December 25, 2012
The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?Jacques Galipeau
Stem Cells (Dayton, Ohio)|October 21, 2016
Reply: "Function of Cryopreserved Mesenchymal Stromal Cells With and Without Interferon-γ Prelicensing Is Context Dependent"Jacques Galipeau
Stem Cells (Dayton, Ohio)|March 31, 2021
Macrophages at the nexus of mesenchymal stromal cell potency: The emerging role of chemokine cooperativityJacques Galipeau
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 12, 2020
Mesenchymal Stromal Cells for Graft-versus-Host Disease: A TrilogyJacques Galipeau
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2023
Macrophages, MIFs, and MSCs: Defining an MOA in murine experimental asthmaJacques Galipeau
Cytotherapy|June 13, 2020
Luc Sensébé, champion of MSCs, diesJacques Galipeau
Blood Advances|May 9, 2020
Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune matchJayeeta Giri, Jacques Galipeau
Cancer Immunology, Immunotherapy : CII|January 25, 2008
TGF beta secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effectClaudia Penafuerte, Jacques Galipeau
Stem Cells Translational Medicine|November 14, 2014
Concise review: engineering the fusion of cytokines for the modulation of immune cellular responses in cancer and autoimmune disordersSpencer Ng, Jacques Galipeau
Journal of Immunology (Baltimore, Md. : 1950)|May 5, 2011
GM-CSF-based fusion cytokines as ligands for immune modulationPatrick Williams, Jacques Galipeau
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Cytotherapy|December 25, 2012
The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?Jacques Galipeau
Stem Cells (Dayton, Ohio)|October 21, 2016
Reply: "Function of Cryopreserved Mesenchymal Stromal Cells With and Without Interferon-γ Prelicensing Is Context Dependent"Jacques Galipeau
Stem Cells (Dayton, Ohio)|March 31, 2021
Macrophages at the nexus of mesenchymal stromal cell potency: The emerging role of chemokine cooperativityJacques Galipeau
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 12, 2020
Mesenchymal Stromal Cells for Graft-versus-Host Disease: A TrilogyJacques Galipeau
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2023
Macrophages, MIFs, and MSCs: Defining an MOA in murine experimental asthmaJacques Galipeau
Cytotherapy|June 13, 2020
Luc Sensébé, champion of MSCs, diesJacques Galipeau
Blood Advances|May 9, 2020
Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune matchJayeeta Giri, Jacques Galipeau
Cancer Immunology, Immunotherapy : CII|January 25, 2008
TGF beta secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effectClaudia Penafuerte, Jacques Galipeau
Stem Cells Translational Medicine|November 14, 2014
Concise review: engineering the fusion of cytokines for the modulation of immune cellular responses in cancer and autoimmune disordersSpencer Ng, Jacques Galipeau
Journal of Immunology (Baltimore, Md. : 1950)|May 5, 2011
GM-CSF-based fusion cytokines as ligands for immune modulationPatrick Williams, Jacques Galipeau
Pageof 20